Biricodar dicitrate

CAS No. 174254-13-8

Biricodar dicitrate( —— )

Catalog No. M35987 CAS No. 174254-13-8

Biricodar dicitrate (VX-710) is a potent MDR inhibitor with no anticancer activity and can be used to study prostate cancer.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 1112 In Stock
25MG 1824 In Stock
50MG 2213 In Stock
100MG 2883 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Biricodar dicitrate
  • Note
    Research use only, not for human use.
  • Brief Description
    Biricodar dicitrate (VX-710) is a potent MDR inhibitor with no anticancer activity and can be used to study prostate cancer.
  • Description
    Biricodar dicitrate (VX-710) is a potent MDR inhibitor with no anticancer activity and can be used to study prostate cancer.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Cell Cycle/DNA Damage
  • Target
    AChR
  • Recptor
    AChR | NF-κB
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    174254-13-8
  • Formula Weight
    987.95
  • Molecular Formula
    C46H57N3O21
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    OC(CC(C(O)=O)(O)CC(O)=O)=O.O=C(C1=CC(OC)=C(C(OC)=C1)OC)C(N2[C@@H](CCCC2)C(OC(CCCC3=CN=CC=C3)CCCC4=CN=CC=C4)=O)=O.OC(CC(C(O)=O)(O)CC(O)=O)=O
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • DMAB-anabaseine dihy...

    DMAB-anabaseine dihydrochloride is an α7-containing neuronal nicotinic receptor partial agonist and an antagonist at α4β2 and other nicotinic receptors.

  • Mitotan

    Mitotane(2,4′-DDD), an isomer of DDD and derivative of DDT, is an antineoplastic medication used in the treatment of adrenocortical carcinoma.

  • (S)-Coclaurine

    (S)-Coclaurine is an antagonist of nAChR isolated from Sarcopetalum harveyanum.